COVID
-
April 14, 2022
VUMC research team receives $1 million grant from AHA to study impact of long-COVID on heart
A research team led by Cyndya Shibao, MD, MSCI, associate professor of Medicine at Vanderbilt University Medical Center (VUMC), has received a three-year, $1-million grant from the American Heart Association to study long-term effects of COVID-19 on the heart and cardiovascular system. -
April 13, 2022
Additional COVID vaccine helps protect transplant patients
Additional booster doses of vaccine against COVID-19 are particularly important for those who are immunosuppressed, namely those who have had solid organ transplants, a new study shows. -
April 13, 2022
Volunteering for vaccine research a family affair
-
April 7, 2022
Study explores parents’ reluctance to flu, COVID vaccines for children
Vanderbilt research found parents who are reluctant to vaccinate their children against the flu are more than five times as likely to decline the COVID-19 vaccine for their children. -
April 6, 2022
Major grant renewal to provide five more years of support for VICTR
Vanderbilt University Medical Center has competed successfully for a third renewal of its Clinical and Translational Science Award by the National Institutes of Health. -
March 31, 2022
Crowe receives national award for COVID antibody research
Vanderbilt's James Crowe Jr., MD, and Michel Nussenzweig, MD, PhD, of The Rockefeller University, have been jointly awarded the 2022 Harrington Prize for Innovation in Medicine for “groundbreaking work” that enabled the use of human antibodies to treat COVID-19. -
March 30, 2022
Uncharted days of the COVID-19 pandemic strengthen the Vanderbilt Vaccine Research Program team.
“There’s something about having a band of brothers, where you’re all focused on the same thing, and your noses are all pointed in the same direction."